RAS Inhibitors 'Underused' in Renal Patients After an MI, Says New Research Medscape Lead author Dr James B Wetmore (Hennepin County Medical Center, Minneapolis, MN) told heartwire from Medscape that renal function "was accorded disproportionate weight" over EF status when it came to therapy decisions. "And it may be deterring some ...

...